Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Budiawan,
Right arrow Articles by Eder, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Budiawan,
Right arrow Articles by Eder, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 21, No. 6, 1191-1196, June 2000
© 2000 Oxford University Press

Carcinogenesis

Detection of 1,N2-propanodeoxyguanosine adducts in DNA of Fischer 344 rats by an adapted 32P-post-labeling technique after per os application of crotonaldehyde

Budiawan and Erwin Eder1,2

Department of Chemistry, Faculty of Sciences, University of Indonesia, Jakarta, Indonesia and
1 Department of Toxicology, University of Würzburg, Würzburg, Germany

Crotonaldehyde is an important industrial chemical to which humans and animals are ubiquitously exposed. The main intake occurs via food, tobacco smoke and possibly also via beverages. Estimation of intake via the different routes is difficult since the data available on exposure are inconsistent. Crotonaldehyde is genotoxic, mutagenic and carcinogenic and forms 1,N2-propanodeoxyguanosine adducts as the main DNA adducts. We have developed a 32P-post-labeling method for these adducts based on nuclease P1 enrichment and polyethyleneimine–cellulose TLC which allows reliable detection with a detection limit of 3 adducts/109 nucleotides, a labeling efficiency of 80–90% and a recovery of 38%. Using this method we found crotonaldehyde adducts in different organs of Fischer 344 rats after a single gavage of high doses of 300 and 200 mg/kg body wt in the range 0.3–3.2 ± 0.4 adducts/108 nucleotides and after repeated gavage of low doses of 10 and 1 mg/kg body wt (five times a week for 6 weeks) 6.2 ± 0.2 and 2.0 ± 0.4 adducts/108nucleotides, but not in untreated animals nor in calf thymus DNA not treated with crotonaldehyde. In contrast to our results, Chung and co-workers found adducts in tissue of untreated Fischer 344 rats. This discrepancy could depend on the different methods used but also on differences in exposure of the animals via food or due to animal housing, etc.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
T. S. Dexheimer, A. Kozekova, C. J. Rizzo, M. P. Stone, and Y. Pommier
The modulation of topoisomerase I-mediated DNA cleavage and the induction of DNA-topoisomerase I crosslinks by crotonaldehyde-derived DNA adducts
Nucleic Acids Res., July 1, 2008; 36(12): 4128 - 4136.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
C. L. Sprague and A. A. Elfarra
DETECTION OF CARBOXYLIC ACIDS AND INHIBITION OF HIPPURIC ACID FORMATION IN RATS TREATED WITH 3-BUTENE-1,2-DIOL, A MAJOR METABOLITE OF 1,3-BUTADIENE
Drug Metab. Dispos., August 1, 2003; 31(8): 986 - 992.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.